JEIL PHARMACEUTICAL CO., LTD.

🇰🇷South Korea
Ownership
Public
Employees
999
Market Cap
-
Website
http://www.jeilpharm.co.kr

A Study of Lubiprostone to Treat Constipation

Recruiting
Conditions
Interventions
First Posted Date
2021-04-27
Last Posted Date
2022-11-17
Lead Sponsor
Jeil Pharmaceutical Co., Ltd.
Target Recruit Count
3000
Registration Number
NCT04861233
Locations
🇰🇷

Dongguk University Ilsan Hospital, Goyang-si, Gyeonggi-do, Korea, Republic of

The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Adult Volunteers Volunteers

First Posted Date
2018-10-16
Last Posted Date
2019-08-29
Lead Sponsor
Jeil Pharmaceutical Co., Ltd.
Target Recruit Count
49
Registration Number
NCT03707899
Locations
🇰🇷

Chonbuk National University Hospital, Jeonju, Korea, Republic of

The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers.

First Posted Date
2018-10-01
Last Posted Date
2019-03-29
Lead Sponsor
Jeil Pharmaceutical Co., Ltd.
Target Recruit Count
42
Registration Number
NCT03690778
Locations
🇰🇷

Inha University Hospital, Incheon, Korea, Republic of

Pilot Clinical Trial to Evaluate the UNI-DEB for Unresectable Hepatocellular Carcinoma

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2018-06-20
Last Posted Date
2018-06-21
Lead Sponsor
Jeil Pharmaceutical Co., Ltd.
Target Recruit Count
10
Registration Number
NCT03564405
Locations
🇰🇷

Catholic University Seoul St. Mary Hospital, Seoul, Korea, Republic of

Clinical Trial to Evaluate the Efficacy and Safety of UNI-DEB for Unresectable Hepatocellular Carcinoma

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2018-05-23
Last Posted Date
2018-10-01
Lead Sponsor
Jeil Pharmaceutical Co., Ltd.
Target Recruit Count
62
Registration Number
NCT03533920
Locations
🇰🇷

Seoul National University Bundang Hospital, Gyeonggi-do, Korea, Republic of

🇰🇷

The Catholic University of Korea, Uijeongbu ST. Mary's Hospital, Gyeonggi-do, Korea, Republic of

🇰🇷

Inha University Hospital, Incheon, Korea, Republic of

and more 5 locations

Drug-drug Interaction Following Oral Administration of Telmisartan/Amlodipine and Atorvastatin in Healthy Adult Volunteers

First Posted Date
2018-03-09
Last Posted Date
2018-03-12
Lead Sponsor
Jeil Pharmaceutical Co., Ltd.
Target Recruit Count
32
Registration Number
NCT03461081
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

Compare the Pharmacokinetic Characteristics and the Safety Between Zeropix and Champix in Healthy Adult Male Subjects.

Phase 1
Completed
Conditions
Interventions
First Posted Date
2017-12-05
Last Posted Date
2017-12-05
Lead Sponsor
Jeil Pharmaceutical Co., Ltd.
Target Recruit Count
31
Registration Number
NCT03362008
Locations
🇰🇷

Inha University Hospital, Incheon, Korea, Republic of

The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Male Volunteers Volunteers

First Posted Date
2017-08-11
Last Posted Date
2017-12-26
Lead Sponsor
Jeil Pharmaceutical Co., Ltd.
Target Recruit Count
40
Registration Number
NCT03247140
Locations
🇰🇷

Chonbuk National University Hospital, Jeonju, Korea, Republic of

Study to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine/Rosuvastatin

First Posted Date
2017-03-23
Last Posted Date
2018-07-06
Lead Sponsor
Jeil Pharmaceutical Co., Ltd.
Target Recruit Count
126
Registration Number
NCT03088254
Locations
🇰🇷

Ewha Womans University Mokdong Hospital, Seoul, Korea, Republic of

🇰🇷

Kangbuk Samsung Hospital, Seoul, Korea, Republic of

🇰🇷

Korea University Anam Hospital, Seoul, Korea, Republic of

and more 9 locations
© Copyright 2024. All Rights Reserved by MedPath